Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review

Bulletin of the World Health Organization

Volumn 82, Issue 12, 2004, Pages 935-939

  Connor, Jennie ^a   Rafter, Natasha ^a   Rodgers, Anthony ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Drug combinations; Drug packaging; Patient compliance; Randomized controlled trials; Review literature (source: MeSH, NLM); Self administration; Tablets administration and dosage; Treatment outcome

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; VITAMIN;

ADMINISTRATION; DISEASE CONTROL; DRUG PRESCRIBING; HEALTH CARE;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; DRUG COMBINATION; DRUG DOSE REGIMEN; DRUG PACKAGING; DRUG SELF ADMINISTRATION; FOLLOW UP; METHODOLOGY; PATIENT COMPLIANCE; POLYPHARMACY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

DRUG COMBINATIONS; DRUG PACKAGING; HUMANS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS; SELF ADMINISTRATION; TABLETS; TREATMENT OUTCOME;

EID: 11244339918     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Morrison A, Wertheimer A, Berger M. Interventions to improve antihypertensive drug adherence: A quantitative review of trials. Formulary 2000;35:234-55.
2. Benner J, Glynn R, Mogun H, Neumann P, Weinstein M, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
3. World Health Organization. Adherence to long-term therapies. Evidence for Action. Geneva: World Health Organization; 2003.
4. McDonald H, Garg A, Haynes R. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002;288:2868-79.
5. Maggiolo F, Ripimonti D, Arici C, Gregis G, Quinzan G, Camacho G, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clinical Trials 2002;3:371-8.
6. Murray M, Birt J, Manatunga A, Darnell JC. Medication compliance in elderly outpatients using twice daily dosing and unit-of-use packaging. Annals of Pharmacotherapy 1993;27:616-21.
7. Paes A, Bakker A, Soe-Agnie C. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-17.
8. World Health Organization. Secondary prevention of noncommunicable disease in low and middle income countries through community-based and health service interventions. WHO-Wellcome Trust Meeting Report Geneva: WHO; 2002.
9. Wald N, Law M. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1423.
10. Bristol-Myers Squibb Pharmaceutical Research Institute. Advisory Committee Briefing Book for the NDA of Pravachol. Bristol-Myers Squibb Company; 2002.
11. Su W, Perng R. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up. International Journal of Tuberculosis and Lung Disease 2002;6:1029-32.
12. Yeboah-Antwi K, Gyapong J, Asare I, Barnish G, Evans D, Adjei S. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bulletin of the World Health Organization 2001;79:394-9.
13. Simmons D, Upjohn M, Gamble G. Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized controlled trial. Diabetes Care 2000;23:153-6.
14. Eron J, Yetzer E, Ruane P, Becker S, Sawyerr G, Fisher R, et al. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS 2000;14:671-81.
15. Revankar C, Nivedita G, Sorensen B, Naik S. Further observations on MDT blister-calendar packs in vertical leprosy eradication programmes - a multicentre study (Phase II), Leprosy Review 1993;64:250-4.
16. Ware G, Holford N, Davison J. Unit dose dispensing. New Zealand Medical Journal 1991;104:495-7.
17. Binstock M, Franklin K. A comparison of compliance techniques on the control of high blood pressure. American Journal of Hypertension 1988;1:S192-4.
18. Wong B, Norman D. Evaluation of a novel medication aid, the calendar blister-pak, and its effect on drug compliance in a geriatric outpatient clinic. Journal of the American Geriatric Society 1987;35:21-6.
19. Geiter L, O'Brien R, Combs D, Snider D. United States Public Health Service Tuberculosis Therapy Trial 21: Preliminary results of an evaluation of a combination tablet of isoniazid, rifampicin and pyrazinamide. Tubercle 1987;68:41-6.
20. Becker L, Glanz K, Sobel E, Mossey J, Zinn S, Andrews Knott K. A randomized trial of special packaging of antihypertensive medications. Journal of Family Practice 1986;22:357-61.
21. Crome P, Curl B, Boswell M, Corless D, Lewis R. Assessment of a new calendar pack - the 'C-Pak'. Age and Ageing 1982;11:275-9.
22. Rehder T, McCoy L, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. American Journal of Hospital Pharmacy 1980;37:379-85.
23. Crome P, Akehurst M, Keet J. Drug compliance in elderly hospital in-patients: Trial of the Dosett box. The Practitioner 1980;224:782-5.
24. Huang HY, Maguire M, Miller E, Appel L. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. American Journal of Epidemiology 2000;152:780-7.
25. Haynes R, McKibbon K, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-6.
26. Rodgers A. A cure for cardiovascular disease? BMJ 2003;326:1407-8.